NorthWest Biotherapeutics Inc (NWBO)

[jammyjames]

Ex i can't believe you don't own any shares here. Granted there are some trust issues with management. But the upside is absolutely massive and by you own estimates the gold standard readout in oncology trials is going to come out positive for dcvax-l.

I purposely asked you

"let's say that the trial failed to meet the primary PFS endpoint and there was a futility recommendation from the DMB in mid 2015 (which seems the most likely scenario). Do you think DCVax-L would still be approved if NWBO can show a statistically significant OS hazard ratio?"

To which you responded
"Jammy, I think the answer is yes, a clear OS benefit would outweigh the formal failure of the the statistical trial."

So it sounds like by your own best estimate that you think dcvax-l will be approved. For sure the guestimate game has error and you never know what confounding factor my appear upon unblinding but it's our best guess and with that upside relative to the risk a stats man like yourself should be going crazy!